These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28252)

  • 21. Proceedings: Behavioral effects of direct and indirect acting dopaminergic agonists.
    Moore KE
    Psychopharmacol Bull; 1974 Jul; 10(3):41-2. PubMed ID: 4419323
    [No Abstract]   [Full Text] [Related]  

  • 22. [Relation between the nature of psychotropic effects on emotional reactivity and behavior in stress situations and the status of the brain's catecholaminergic systems].
    Bondarenko NA; Val'dman AV; Kamysheva VA
    Biull Eksp Biol Med; 1981 Jul; 92(7):35-8. PubMed ID: 6117338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Characteristics of "behavior modification" induced by dopaminergic stimulation].
    Costentin J; Baudry M; Marcais H; Martres MP; Protais P
    Arch Farmacol Toxicol; 1978 Apr; 4(1):64-5. PubMed ID: 29573
    [No Abstract]   [Full Text] [Related]  

  • 24. [On the mechanism of therapeutic actions of psychotropic drugs (author's transl)].
    Mroji T
    No To Shinkei; 1979 Nov; 31(11):1075-97. PubMed ID: 43160
    [No Abstract]   [Full Text] [Related]  

  • 25. Behavioural sequelae of dopaminergic degeneration: postsynaptic supersensitivity?
    Creese I; Iversen SD
    Psychopharmacol Bull; 1975 Oct; 11(4):12-3. PubMed ID: 1197588
    [No Abstract]   [Full Text] [Related]  

  • 26. The effects of acrylamide on the behavioral suppression produced by psychoactive agents.
    Tilson HA; Squibb RE
    Neurotoxicology; 1982 Jul; 3(1):113-20. PubMed ID: 6890182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. REM sleep deprivation and dopamine in the CNS.
    Carlini EA
    Rev Pure Appl Pharmacol Sci; 1983; 4(1):1-25. PubMed ID: 6142502
    [No Abstract]   [Full Text] [Related]  

  • 28. Serotonin/dopamine interaction--focus on 5-HT2C receptor, a new target of psychotropic drugs.
    Di Giovanni G; Di Matteo V; Esposito E
    Indian J Exp Biol; 2002 Dec; 40(12):1344-52. PubMed ID: 12974395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neurochemical pharmacology: current problems and prospects].
    Raevskiĭ KS
    Vestn Akad Med Nauk SSSR; 1982; (5):64-9. PubMed ID: 6125069
    [No Abstract]   [Full Text] [Related]  

  • 30. [Psychotropic drugs and behavior].
    Lôo H; Olié JP; Poirier MF; Amado I
    Ann Pharm Fr; 1998; 56(2):75-82. PubMed ID: 9770027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current developments in the pharmacology of the dopaminergic receptors. III].
    Nechifor M; Lucaci L
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(3):510, 516, 566. PubMed ID: 2576889
    [No Abstract]   [Full Text] [Related]  

  • 32. Stress-induced neurological impairments in an animal model of parkinsonism.
    Snyder AM; Stricker EM; Zigmond MJ
    Ann Neurol; 1985 Nov; 18(5):544-51. PubMed ID: 3935041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Brain dopamine receptors: structure, functional role, and modulation by psychotropic substances].
    Raevskiĭ KS
    Vopr Med Khim; 1997; 43(6):553-65. PubMed ID: 9503573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissociable properties of dopamine neurons im the nigrostriatal and mesolimbic dopamine systems.
    Koob GF; Del Fiacco M; Iversen SD
    Adv Biochem Psychopharmacol; 1977; 16():589-95. PubMed ID: 560793
    [No Abstract]   [Full Text] [Related]  

  • 35. Genetic control of the number of dopamine neurons in the brain: relationship to behavior and responses to psychoactive drugs.
    Reis DJ; Fink JS; Baker H
    Res Publ Assoc Res Nerv Ment Dis; 1983; 60():55-75. PubMed ID: 6130586
    [No Abstract]   [Full Text] [Related]  

  • 36. Noradrenergic influences on dopamine-dependent behaviour in rats [proceedings].
    Pycock C
    Br J Pharmacol; 1976 Jul; 57(3):424P. PubMed ID: 974325
    [No Abstract]   [Full Text] [Related]  

  • 37. [Mesolimbic system of the brain and its participation in the action of psychotropic substances (a review of the literature)].
    Arushanian EB
    Farmakol Toksikol; 1977; 40(5):623-30. PubMed ID: 336388
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of chronic ethanol administration on central neurotransmitter mechanisms.
    Liljequist S; Engel J
    Med Biol; 1979 Aug; 57(4):199-210. PubMed ID: 41985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prenatal psychotropic drug exposure and the development of central dopaminergic and cholinergic neurotransmitter systems.
    Friedhoff AJ; Miller JC
    Monogr Neural Sci; 1983; 9():91-8. PubMed ID: 6310384
    [No Abstract]   [Full Text] [Related]  

  • 40. [Recent advance in neuropharmacology (author's transl)].
    Kayama Y
    Masui; 1978 Mar; 27(3):219-28. PubMed ID: 25972
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.